Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1964 1
1965 3
1966 2
1967 6
1968 5
1969 5
1970 10
1971 4
1972 10
1973 5
1974 2
1976 2
1977 2
1978 1
1979 6
1980 2
1981 3
1982 6
1983 5
1984 4
1985 8
1986 7
1987 7
1988 8
1989 13
1990 17
1991 17
1992 20
1993 21
1994 17
1995 21
1996 29
1997 28
1998 37
1999 46
2000 53
2001 67
2002 41
2003 77
2004 86
2005 114
2006 134
2007 156
2008 157
2009 180
2010 196
2011 215
2012 224
2013 265
2014 291
2015 313
2016 347
2017 407
2018 439
2019 462
2020 623
2021 770
2022 826
2023 742
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

6,814 results

Results by year

Filters applied: . Clear all
Page 1
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
Xu H, Li S, Liu J, Cheng J, Kang L, Li W, Zhong Y, Wei C, Fu L, Qi J, Zhang Y, You M, Zhou Z, Zhang C, Su H, Yao S, Zhou Z, Shi Y, Deng R, Lv Q, Li F, Qi F, Chen J, Zhang S, Ma X, Xu Z, Li S, Xu Y, Peng K, Shi Y, Jiang H, Gao GF, Huang L. Xu H, et al. Among authors: yao s. Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120. doi: 10.1073/pnas.2301775120. Epub 2023 Apr 24. Proc Natl Acad Sci U S A. 2023. PMID: 37094153 Free PMC article.
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial.
Li N, Zhu J, Yin R, Wang J, Pan L, Kong B, Zheng H, Liu J, Wu X, Wang L, Huang Y, Wang K, Zou D, Zhao H, Wang C, Lu W, Lin A, Lou G, Li G, Qu P, Yang H, Zhang Y, Cai H, Pan Y, Hao M, Liu Z, Cui H, Yang Y, Yao S, Zhen X, Hang W, Hou J, Wang J, Wu L. Li N, et al. Among authors: yao s. JAMA Oncol. 2023 Sep 1;9(9):1230-1237. doi: 10.1001/jamaoncol.2023.2283. JAMA Oncol. 2023. PMID: 37440217 Free PMC article. Clinical Trial.
An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma.
Chen YX, Wang ZX, Jin Y, Zhao Q, Liu ZX, Zuo ZX, Ju HQ, Cui C, Yao J, Zhang Y, Li M, Feng J, Tian L, Xia XJ, Feng H, Yao S, Wang FH, Li YH, Wang F, Xu RH. Chen YX, et al. Among authors: yao s. Cancer Cell. 2023 May 8;41(5):919-932.e5. doi: 10.1016/j.ccell.2023.03.016. Epub 2023 Apr 13. Cancer Cell. 2023. PMID: 37059106
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B; Biobank Japan; Blok MJ, Boddicker N, Brunet J, Burnside ES, Calvello M, Campbell I, Chan SH, Chen F, Chiang JB, Coppa A, Cortesi L, Crujeiras-González A; Consortium CZECANCA; De Leeneer K, De Putter R, DePersia A, Devereux L, Domchek S, Efremidis A, Engel C, Ernst C, Evans DGR, Feliubadaló L, Fostira F, Fuentes-Ríos O, Gómez-García EB, González S, Haiman C, Hansen TVO, Hauke J, Hodge J, Hu C, Huang H, Ishak NDB, Iwasaki Y, Konstantopoulou I, Kraft P, Lacey J, Lázaro C, Li N, Lim WK, Lindstrom S, Lori A, Martinez E, Martins A, Matsuda K, Matullo G, McInerny S, Michailidou K, Montagna M, Monteiro ANA, Mori L, Nathanson K, Neuhausen SL, Nevanlinna H, Olson JE, Palmer J, Pasini B, Patel A, Piane M, Poppe B, Radice P, Renieri A, Resta N, Richardson ME, Rosseel T, Ruddy KJ, Santamariña M, Dos Santos ES, Teras L, Toland AE, Trentham-Dietz A, Vachon CM, Volk AE, Weber-Lassalle N, Weitzel JN, Wiesmuller L, Winham S, Yadav S, Yannoukakos D, Yao S, Zampiga V, Zethoven M, Zhang ZW, Zima T, Spurdle AB, Vega A, Rossing M, Del Valle J, De… See abstract for full author list ➔ Stolarova L, et al. Among authors: yao s. Clin Cancer Res. 2023 Aug 15;29(16):3037-3050. doi: 10.1158/1078-0432.CCR-23-0212. Clin Cancer Res. 2023. PMID: 37449874 Free PMC article.
Autophagy: Regulator of cell death.
Liu S, Yao S, Yang H, Liu S, Wang Y. Liu S, et al. Among authors: yao s. Cell Death Dis. 2023 Oct 4;14(10):648. doi: 10.1038/s41419-023-06154-8. Cell Death Dis. 2023. PMID: 37794028 Free PMC article. Review.
Intracellular chloride channel 1 and tumor.
Zhang L, Chen X, Yao S, Zheng L, Yang X, Wang Y, Li X, Wu E, Tuo B. Zhang L, et al. Among authors: yao s. Am J Cancer Res. 2023 Aug 15;13(8):3300-3314. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693147 Free PMC article. Review.
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.
Dong X, Xia S, Du S, Zhu MH, Lai X, Yao SQ, Chen HZ, Fang C. Dong X, et al. Among authors: yao sq. ACS Cent Sci. 2023 Sep 22;9(10):1864-1893. doi: 10.1021/acscentsci.3c00702. eCollection 2023 Oct 25. ACS Cent Sci. 2023. PMID: 37901179 Free PMC article. Review.
Polymorphic nanostarch-mediated assembly of bioactives.
Yao S, Zhu Q, Xianyu Y, Liu D, Xu E. Yao S, et al. Carbohydr Polym. 2024 Jan 15;324:121474. doi: 10.1016/j.carbpol.2023.121474. Epub 2023 Oct 10. Carbohydr Polym. 2024. PMID: 37985040 Review.
Programmed cell death of periodontal ligament cells.
He W, Fu Y, Yao S, Huang L. He W, et al. Among authors: yao s. J Cell Physiol. 2023 Aug;238(8):1768-1787. doi: 10.1002/jcp.31091. Epub 2023 Aug 11. J Cell Physiol. 2023. PMID: 37566596 Review.
6,814 results